TP53 and breast cancer: Although, earlier studies with other breast cancer cells containing functional ER and wild type p53 showed cell growth inhibition and apoptosis induced by andrographolide [16, 17], reports on the effect on this particular triple negative breast cancer (TNBC) cell line are scanty.